936
Views
6
CrossRef citations to date
0
Altmetric
Editorial

Is the incidence of parasitic lung diseases increasing, and how may this affect modern respiratory medicine?

Pages 339-344 | Published online: 09 Jan 2014

References

  • Vijayan VK. Immunopathogenesis and treatment of eosinophilic lung diseases in the tropics. In: Tropical Lung Disease (Lung Biology in Health and Disease). Sharma OP (Ed.). Taylor & Francis Group, NY, USA, 211, 195–239 (2006).
  • Vijayan VK. Tropical parasitic lung diseases. Indian J. Chest Dis. Allied Dis.50, 49–66 (2008).
  • Brooks DR, Hoberg EP. How will global climate change affect parasite host assemblages? Trends Parasitol.23, 571–574 (2007).
  • Vijayan VK. How to diagnose and manage common parasitic pneumonias? Curr. Opin. Pulm. Med.13, 218–224 (2007).
  • Vijayan VK. Parasitic lung infections. Curr. Opin. Pulm. Med.15, 274–282 (2009).
  • Ackers JP, Mirelman D. Progress in research on Entamoeba histolytica pathogenesis. Curr. Opin. Microbiol.9, 367–373 (2006).
  • Shamsuzzaman SM, Hashiguchi Y. Thoracic amoebiasis. Clin. Chest Med.23, 479–492 (2002).
  • Hsu MS, Hsieh SM, Chen MY et al. Association between amebic liver abscess and human immunodeficiency virus infection in Taiwanese subjects. BMC Infect. Dis.8, 48 (2008).
  • Tan LK, Yacoub S, Scott S et al. Acute lung injury and other serious complications of Plasmodium vivax malaria. Lancet Infect. Dis.8, 449–454 (2008).
  • Mharakurwa S, Simoloka C, Thuma PE et al. PCR detection of Plasmodium falciparum in human urine and saliva samples. Malar. J.5, 103 (2006).
  • Rosenthal PJ. Artesunate for the treatment of severe falciparum malaria. N. Engl. J. Med.358, 1829–1836 (2008).
  • Praygod G, De Fray A, Eisenhut M. Artemisin derivatives versus quinine in treating severe malaria in children: a systematic review. Malar. J.7, 210 (2008).
  • WHO. Guidelines for the treatment of malaria. WHO, Geneva, Switzerland, 1–266 (2006).
  • Freedman DO. Clinical practice: malaria prevention in short-term travelers. N. Engl. J. Med.359, 603–612 (2008).
  • Hassan Sel-D, Malik EM, Okoued SI, Eltayeb EM. Retention and efficacy of long-lasting insecticide-treated nets distributed in eastern Sudan: a two-step community-based study. Malar. J.7, 85 (2008).
  • Vannier E, Gewurz BE, Krause PJ. Human babesiosis. Infect. Dis. Clin. N. Am.22, 469–488 (2008).
  • Cirino CM, Leitman SF, Williams E et al. Transfusion-associated babesiosis with an atypical time course after nonmyeloablative transplantation for sickle cell disease. Ann. Intern. Med.148, 794–795 (2008).
  • Noskoviak K, Broome E. Images in clinical medicine: babesiosis. N. Engl. J. Med.358, e19 (2008).
  • Boustani MR, Lepore TJ, Gelfand JA, Lazarus DS. Acute respiratory failure in patients treated for babesiosis. Am. J. Respir. Crit. Care Med.149, 1689–1691 (1994).
  • Raju M, Salazar JC, Leopold H, Krause PJ. Atovaquone and azithromycin treatment for babesiosis in an infant. Pediatr. Infect. Dis.26, 181–183 (2007).
  • Piscopo TV, Mallia AC. Leishmaniasis. Postgrad. Med. J.82, 649–657 (2006).
  • Morales P, Torres JJ, Salavert M et al. Visceral leishmaniasis in lung transplantation. Transplantation Proc.35, 2001–2003 (2003).
  • Deborggraeve S, Laurent T, Espinosa D et al. A simplified and standardized polymerase chain reaction format for the diagnosis of leishmaniasis. J. Infect. Dis.198, 1565–1572 (2008).
  • Deborggraeve S, Boelaert M, Rijal S et al. Diagnostic accuracy of a new Leishmania PCR for clinical visceral leishmaniasis in Nepal and its role in diagnosis of disease. Trop. Med. Int. Health.13, 1378–1383 (2008).
  • Croft SL, Engel J. Miltefosine: discovery of the anti-leishmanial activity of phospholipid derivatives. Trans. R. Soc. Trop. Med. Hyg.100(Suppl. 1), 54–58 (2006).
  • Dodds EM. Toxoplasmosis. Curr. Opin. Ophthalmol.17, 557–561 (2006).
  • Nash G, Kerschmann RL, Herndier B, Dubey JP. The pathological manifestations of pulmonary toxoplasmosis in the acquired immunodeficiency syndrome. Hum. Pathol.25, 652–658 (1994).
  • Duarte AG, Sattar F, Granwehr B et al. Disseminated acanthamebiasis after lung transplantation. J. Heart Lung Transplant.25, 237–240 (2006).
  • Corti M, Villafane MF, Muzzio E et al. Pulmonary cryptosporidiais in AIDS patients. Rev. Argent. Microbiol.40, 106–108 (2008).
  • Martinez-Giron R, Esteban JG, Ribas A, Doganci L. Protozoa in respiratory pathology: a review. Eur. Respir. J.32, 1354–1370 (2008).
  • Ghoshal UC, Ghoshal U, Jain M et al.Strongyloides stercoralis infestation associated with septicemia due to intestinal transmural migration of bacteria. J. Gastroenterol. Hepatol.17, 1331–1333 (2002).
  • Gorman SR, Craven DE. Strongyloides stercoralis hyperinfection. N. Engl. J. Med.359, e12 (2008).
  • Vijayan VK. Tropical pulmonary eosinophilia. Curr. Opin. Pulm. Med.13, 428–433 (2007).
  • Jiva TM, Israel RH, Poe RH. Tropical pulmonary eosinophilia masquerading as acute bronchial asthma. Respiration63, 55–58 (1996).
  • Cooray JH, Ismail MM. Re-examination of the diagnostic criteria of tropical pulmonary eosinophilia. Respir. Med.93, 655–659 (1999).
  • Rom WN, Vijayan VK, Cornelius MJ et al. Persistent lower respiratory tract inflammation associated with interstitial lung disease in patients with tropical pulmonary eosinophilia following treatment with diethylcarbamazine. Am. Rev. Respir. Dis.142, 1088–1092 (1990).
  • Oshiro Y, Murayama S, Sunagawa U et al. Pulmonary dirofilariasis: computed tomographic findings and correlation with pathologic features. J. Comput. Assist. Tomogr.28, 796–800 (2004).
  • Miyoshi T, Tsubouchi H, Iwasaki A et al. Human pulmonary dirofilariasis: a case report and review of the recent Japanese literature. Respirology11, 343–347 (2006).
  • Hisamatsu Y, Ishii H, Kai N et al. Case of toxocariasis showing migratory nodular shadows with halos. Nihon Kokyuki Gakkai Zasshi46, 420–424 (2008).
  • Bruschi F, Murrell K. Trichinellosis. In: Tropical Infectious Diseases: Principles, Pathogens and Practice (Volume 2). Guerrant R, Walker DH, Weller PF (Eds). Elsevier Science Health Science Division, Churchill Livingstone, PA, USA, 917–925 (1999).
  • Gomez-Morales MA, Ludovisis A, Amati M et al. Validation of an ELISA for the diagnosis of human trichinellosis. Clin. Vaccine Immunol.15, 1723–1729 (2008).
  • Kuzucu A. Parasitic diseases of the respiratory tract. Curr. Opin. Pulm. Med.12, 212–221 (2006).
  • Fanne RA, Khamaisi M, Mevorach D et al. Spontaneous rupture of lung echinococcal cyst causing anaphylactic shock and respiratory distress syndrome. Thorax61, 550 (2006).
  • Kavukcu S, Kilic D, Tokat AO et al. Parenchyma-preserving surgery in the management of pulmonary hydatid cysts. J. Invest. Surg.19, 61–68 (2006).
  • Haralabidis S, Diakou A, Frydas S et al. Long-term evaluation of patients with hydatidosis treated with albendazole and praziquantel. Int. J. Immunopathol. Pharmacol.21, 429–435 (2008).
  • Gottstein B, Reichen J. Hydatid lung disease. In: Lung Biology in Health and Disease: Tropical Lung Disease (2nd Edition). Sharma OP (Ed.). Taylor & Francis Group, NY, USA, 327–350 (2006).
  • Doherty JF, Moody AH, Wright SG. Katayama fever; an acute manifestation of schistosomiasis. BMJ313, 1071–1072 (1996).
  • Ross AG, Vickers D, Olds GR et al. Katayama syndrome. Lancet Infect. Dis.7, 218–224 (2007).
  • Lapa MS, Ferreira EV, Jardim C et al. Clinical characteristics of pulmonary hypertension patients in two reference centres in the city of Sao Paulo. Rev. Assoc. Med. Bras.52, 139–143 (2006).
  • Utzinger J, Xiao SH, Tanner M, Keiser J. Artemisinins for schistosomiasis and beyond. Curr. Opin. Investig. Drugs8, 105–116 (2007).
  • Touré S, Zhang Y, Bosqué-Oliva E et al. Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso. Bull. World Health Organ.86, 780–787 (2008).
  • Strobel M, Veasna D, Saykham M et al. Pleuro–pulmonary paragonimiasis. Med. Mal. Infect.35, 476–481 (2005).
  • Keiser J, Engels D, Buscher G, Utzinger J. Triclabendazole for the treatment of fascioliasis and paragonimiasis. Expert Opin. Investig. Drugs14, 1513–1526 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.